Teva Pharmaceutical 2016-2019 Financial Outlook

Loading viewer...

investor_presentation

Format: PDF investor_presentation

Teva Pharmaceutical Industries' preliminary financial outlook and guidance for 2016-2019, presented July 2016. The presentation outlines management expectations including the impact of the pending Allergan generics acquisition and operational strategy through 2019.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Teva Pharmaceutical Industries

View all →

Teva Pharmaceutical PIVOT TO GROWTH Investor Presentation May 2023

investor_presentation

77 Pages

Teva Pharmaceutical Q1 2023 Earnings Results

earnings

Similar investor_presentations from other companies

Browse all →

SC Johnson Investor Presentation - Beautifying and Preserving Spaces

investor_presentation

25 Pages

SC Johnson

Wellington International Airport 6.5 Year Retail Bond Offer 2024

investor_presentation